Human Tissue Testing Beats Animal Trials | Andrei Georgescu

Vivodyne claims its automated human-tissue labs predict drug toxicity/efficacy far more accurately than animal models, potentially reshaping preclinical drug development.

• 92-94% predictive accuracy: Vivodyne's automated human tissue labs hit 92-94% accuracy on toxicity/efficacy signals, versus 43% for mice and 50-63% for primates.
• Massive scale already live: The company can grow and test 3 million human tissues annually today across 12 robotic "Hive Labs," more throughput than total US clinical trial volume.

Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.